FUNCTION OF WHITE BLOOD CELLS AND THEIR APOPTOTIC ACTIVITY IN PATIENTS WITH CHRONIC RENAL FAILURE ON HEMODYALISIS
- Authors: Osikov M.1, Gizinger O.1, Telesheva L.1, Ageev Y.1, Cherepanov D.1, Akleev A.1
-
Affiliations:
- South Ural State Medical University
- Issue: Vol 25, No 6 (2014)
- Pages: 21-24
- Section: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/116015
- ID: 116015
Cite item
Abstract
Full Text
About the authors
M. Osikov
South Ural State Medical University
O. Gizinger
South Ural State Medical University
Email: ogizinger@gmail.com
L. Telesheva
South Ural State Medical University
Yu. Ageev
South Ural State Medical University
D. Cherepanov
South Ural State Medical University
A. Akleev
South Ural State Medical University
References
- Волгина Г.В. Вторичный гиперпаратиреоз при хронической почечной недостаточности. Лечение активными метаболитами витамина D // Нефрология и диализ. - 2004; 6 (2): 116-24.
- Осиков М.В., Григорьев Т.А., Агеев Ю.И. Эфферентные и антиоксидантные свойства эритропоэтина при хронической почечной недостаточности // Эфферентная терапия. - 2011; 17 (4): 7-13.
- Осиков М.В., Григорьев Т.А., Федосов А.А. Роль эритропоэтина в реализации тромбоцитарно-клеточных взаимодействий в крови при хронической почечной недостаточности // Фундаментальные исследования. - 2012; 10-2: 285-9.
- Осиков М.В., Григорьев Т.А., Федосов А.А. Современные представления о гемостазиологических эффектах эритропоэтина // Фундаментальные исследования. - 2013; 5-1: 196-200.
- Betjes M., Immune cell dysfunction and inflammation in end-stage renal disease // Nat. Rev. Nephrol. - 2013; 5: 255-65.
- Carrero J., Stenvinkel P. Inflammation in end-stage renal disease-what have we learned in 10 years? // Semin. Dial. - 2010; 23: 498-509.
- Chung B., Kim K., Sun I. et al. Increased interleukin-17 producing effector memory T cells in the end-stage renal disease patients // Immunol. Lett. - 2012; 141: 181-9.
- Cohen G., Hörl W. Immune Dysfunction in Uremia-An Update // Toxins (Basel). - 2012; 24 (4): 962-90.
- Eleftheriadis T., Kartsios C., Pissas G. et al. Increased plasma angiogenin level is associated and may contribute to decreased T-cell zeta-chain expression in hemodialysis patients // Ther. Apher. Dial. - 2013; 17 (1): 48-54.
- Eleftheriadis T., Yiannaki E., Antoniadi G. et al. Plasma indoleamine 2,3-dioxygenase and arginase type I may contribute to decreased blood T-cell count in hemodialysis patients // Ren. Fail. - 2012; 34 (9): 1118-22.
- Fernandez-Fresnedo G., Ramos M., Gonzalez-Pardo M. et al. B lymphopenia in uremia is related to an accelerated in vitro apoptosis and dysregulation of Bcl-2 // Nephrol. Dial. Transplant. - 200; 15: 502-10.
- Kato S., Chmielewski M., Honda H. et al. Aspects of immune dysfunction in end-stage renal disease // Clin. J. Am. Soc. Nephrol. - 2008; 3 (5): 1526-33.
- Litjens N., Huisman M., van den Dorpel M. et al. Impaired immune responses and antigen-specific memory CD4+ T cells in hemodialysis patients // J. Am. Soc. Nephrol. - 2008; 19: 1483-90.
- Meier P., Golshayan D., Blanc E. et al. Oxidized LDL modulates apoptosis of regulatory T cells in patients with ESRD // J. Am. Soc. Nephrol. - 2009; 20: 1368-84.
- Meijers R., Litjens N., de Wit E. et al. Uremia causes premature ageing of the T cell compartment in end-stage renal disease patients // Immun. Ageing. -2012; 9 (1): 19.
- Pahl M., Gollapudi S., Sepassi L. et al. Effect of end-stage renal disease on B-lymphocyte subpopulations, IL-7, BAFF and BAFF receptor expression // Nephrol. Dial. Transplant. - 2010; 25: 205-12.